A multicenter, 12-week, phase 3b trial: a combination solution of mequinol 2%/tretinoin 0.01% vs hydroquinone 4% cream in the treatment of mild to moderate postinflammatory hyperpigmentation [abstract] - Taylor, S C; Callender, V D (J Am Acad Dermatol, 2006)
(Suppl):